Another major buy was in INTELLIA THERAPEUTICS INC (NASDAQ:NTLA), with ARK purchasing 191,705 shares for around $2.18 million through its ARKK ETF. Similar to CRISPR, INTELLIA has seen increased ...

NtRON Bio announced today, following its recent U.S. patent application related to colorectal cancer using the IMPA™ phage engineering technology, it has now completed the filing of two patents for a ...

5 latest biotechnology breakthroughs, from genome sequencing to microbiome manipulation, revolutionizing medicine, ...

Lund University scientists report that repetitive DNA once dismissed as “junk” plays an active role in human brain ...

Chocolate makers are racing to secure the future of cocoa amid climate threats and disease outbreaks. From lab-grown cocoa ...

Things that change the world always arrive out of context for the simple reason that the world hasn’t changed yet. So we ...

The company is now involved in a new project in Winston-Salem. It’s establishing the BioSpherix Center for Cytocentric ...

Unprecedented growth at a CAGR of 39.6% positions CAR T-cell therapy as a transformative force in oncologyDelray Beach, FL, ...

Raleigh sustainable food startup Atlantic Fish Co. has received a $305,000 Small Business Innovation Research (SBIR) grant ...

A joint research team led by Chinese scientists, including researchers from South Korea, Japan, and the U.S., has successfully transplanted genetically modified pig lungs into a brain-dead patient for ...

A lab-made diet sparked a 15-fold boom in bee reproduction, pointing to a possible solution for collapsing colonies.

Curevac N.V. ( ($CVAC) ) has released its Q2 earnings. Here is a breakdown of the information Curevac N.V. presented to its investors. CureVac ...